{"transactions":[{"id":841503,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-16T16:07:41.000Z","date":"2026-03-12","kind":"sale","planned":false,"acquired":false,"shares":5369,"price":50.61,"value":271725.09,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.45 to $50.82. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc., any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":60413,"source":{"system":"sec-edgar","filing":"0001438462-26-000006","document":"wk-form4_1773691657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000143846226000006/wk-form4_1773691657.xml","form_type":"4"}},{"id":881801,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T16:56:53.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4475},"source":{"system":"sec-edgar","filing":"0001438462-26-000004","document":"wk-form4_1772056609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000143846226000004/wk-form4_1772056609.xml","form_type":"4"}},{"id":881800,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T16:56:53.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":4475,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":65782,"source":{"system":"sec-edgar","filing":"0001438462-26-000004","document":"wk-form4_1772056609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000143846226000004/wk-form4_1772056609.xml","form_type":"4"}},{"id":890559,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-02-20T16:39:13.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":4977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option vests on February 18, 2027."}],"balance_after":4977,"derivative":{"exercise_price":50.2,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":4977},"source":{"system":"sec-edgar","filing":"0001438462-26-000002","document":"wk-form4_1771623548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000143846226000002/wk-form4_1771623548.xml","form_type":"4"}},{"id":890558,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-20T16:39:13.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":2989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027."}],"balance_after":2989,"derivative":{"underlying":"Common Stock","underlying_shares":2989},"source":{"system":"sec-edgar","filing":"0001438462-26-000002","document":"wk-form4_1771623548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000143846226000002/wk-form4_1771623548.xml","form_type":"4"}},{"id":940910,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-01-12T16:09:47.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001628280-26-001817","document":"wk-form4_1768252183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000162828026001817/wk-form4_1768252183.xml","form_type":"4"}},{"id":940909,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-12T16:09:47.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":12.98,"value":194700.0,"ownership":{"direct":true},"balance_after":61307,"source":{"system":"sec-edgar","filing":"0001628280-26-001817","document":"wk-form4_1768252183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000162828026001817/wk-form4_1768252183.xml","form_type":"4"}},{"id":1022180,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:11.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the \"Merger Agreement\"), by and among the Issuer, MannKind Corporation (\"Parent\") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's common stock (\"Common Stock\") on October 7, 2025.   Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) was cancelled and converted into the right to receive (i) an amount in cash, without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":3.37,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":6124},"source":{"system":"sec-edgar","filing":"0001193125-25-233534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233534/ownership.xml","form_type":"4"}},{"id":1022179,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:11.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the \"Merger Agreement\"), by and among the Issuer, MannKind Corporation (\"Parent\") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's common stock (\"Common Stock\") on October 7, 2025.   Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) was cancelled and converted into the right to receive (i) an amount in cash, without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":4.53,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001193125-25-233534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233534/ownership.xml","form_type":"4"}},{"id":1022178,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:11.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the \"Merger Agreement\"), by and among the Issuer, MannKind Corporation (\"Parent\") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's common stock (\"Common Stock\") on October 7, 2025.   Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) was cancelled and converted into the right to receive (i) an amount in cash, without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":4.11,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":19750},"source":{"system":"sec-edgar","filing":"0001193125-25-233534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233534/ownership.xml","form_type":"4"}},{"id":1022177,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:11.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the \"Merger Agreement\"), by and among the Issuer, MannKind Corporation (\"Parent\") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's common stock (\"Common Stock\") on October 7, 2025.   Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) was cancelled and converted into the right to receive (i) an amount in cash, without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":3.85,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-25-233534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233534/ownership.xml","form_type":"4"}},{"id":1063822,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-18T16:28:44.000Z","date":"2025-08-14","kind":"sale","planned":false,"acquired":false,"shares":7457,"price":42.26,"value":315132.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.14 to $42.37. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":46307,"source":{"system":"sec-edgar","filing":"0001628280-25-040662","document":"wk-form4_1755548919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000162828025040662/wk-form4_1755548919.xml","form_type":"4"}},{"id":1121268,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T16:48:17.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 3, 2026, or (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":30000,"derivative":{"exercise_price":3.85,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-25-082434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000095017025082434/ownership.xml","form_type":"4"}},{"id":1249404,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-02-24T17:50:53.000Z","date":"2025-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5369},"source":{"system":"sec-edgar","filing":"0001628280-25-007479","document":"wk-form4_1740437446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000162828025007479/wk-form4_1740437446.xml","form_type":"4"}},{"id":1249403,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-24T17:50:53.000Z","date":"2025-02-22","kind":"grant","planned":false,"acquired":true,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53764,"source":{"system":"sec-edgar","filing":"0001628280-25-007479","document":"wk-form4_1740437446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000162828025007479/wk-form4_1740437446.xml","form_type":"4"}},{"id":1252751,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-02-21T16:51:48.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":4475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."}],"balance_after":4475,"derivative":{"underlying":"Common Stock","underlying_shares":4475},"source":{"system":"sec-edgar","filing":"0001628280-25-007191","document":"wk-form4_1740174702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000162828025007191/wk-form4_1740174702.xml","form_type":"4"}},{"id":1252750,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-02-21T16:51:48.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":7296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on February 19, 2026."}],"balance_after":7296,"derivative":{"exercise_price":33.52,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":7296},"source":{"system":"sec-edgar","filing":"0001628280-25-007191","document":"wk-form4_1740174702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000162828025007191/wk-form4_1740174702.xml","form_type":"4"}},{"id":1296286,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-01-23T16:33:53.000Z","date":"2025-01-22","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.13,"exercise_date":"2016-03-03","expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-25-002388","document":"wk-form4_1737668026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000162828025002388/wk-form4_1737668026.xml","form_type":"4"}},{"id":1296285,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-23T16:33:53.000Z","date":"2025-01-22","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":9.13,"value":182600.0,"ownership":{"direct":true},"balance_after":48395,"source":{"system":"sec-edgar","filing":"0001628280-25-002388","document":"wk-form4_1737668026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000162828025002388/wk-form4_1737668026.xml","form_type":"4"}},{"id":1368747,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-12T16:14:14.000Z","date":"2024-11-08","kind":"sale","planned":false,"acquired":false,"shares":8722,"price":36.28,"value":316434.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $36.31. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":28395,"source":{"system":"sec-edgar","filing":"0001628280-24-047152","document":"wk-form4_1731446048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000162828024047152/wk-form4_1731446048.xml","form_type":"4"}},{"id":1480659,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T17:00:14.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":19750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 11, 2025, or (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":19750,"derivative":{"exercise_price":4.11,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":19750},"source":{"system":"sec-edgar","filing":"0000950170-24-073125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000095017024073125/ownership.xml","form_type":"4"}},{"id":1615434,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-27T17:03:26.000Z","date":"2024-02-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3886},"source":{"system":"sec-edgar","filing":"0001104659-24-028278","document":"tm247055-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465924028278/tm247055-18_4seq1.xml","form_type":"4"}},{"id":1615433,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-27T17:03:26.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37117,"source":{"system":"sec-edgar","filing":"0001104659-24-028278","document":"tm247055-18_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465924028278/tm247055-18_4seq1.xml","form_type":"4"}},{"id":1619200,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-26T17:01:19.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025."}],"balance_after":5369,"derivative":{"underlying":"Common Stock","underlying_shares":5369},"source":{"system":"sec-edgar","filing":"0001104659-24-027574","document":"tm247055-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465924027574/tm247055-11_4seq1.xml","form_type":"4"}},{"id":1619199,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-02-26T17:01:19.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":8252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on February 22, 2025."}],"balance_after":8252,"derivative":{"exercise_price":27.94,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":8252},"source":{"system":"sec-edgar","filing":"0001104659-24-027574","document":"tm247055-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465924027574/tm247055-11_4seq1.xml","form_type":"4"}},{"id":1736537,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-11-17T17:00:35.000Z","date":"2023-11-15","kind":"exercise","planned":false,"acquired":false,"shares":7457,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.24,"exercise_date":"2015-01-21","expiration_date":"2024-01-21","underlying":"Common Stock","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001104659-23-119592","document":"tm2331055-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465923119592/tm2331055-1_4seq1.xml","form_type":"4"}},{"id":1736536,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T17:00:35.000Z","date":"2023-11-15","kind":"sale","planned":false,"acquired":false,"shares":5211,"price":28.5,"value":148513.5,"ownership":{"direct":true},"balance_after":33231,"source":{"system":"sec-edgar","filing":"0001104659-23-119592","document":"tm2331055-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465923119592/tm2331055-1_4seq1.xml","form_type":"4"}},{"id":1736535,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T17:00:35.000Z","date":"2023-11-15","kind":"sale","planned":false,"acquired":false,"shares":3882,"price":28.5,"value":110637.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.49 to $28.53, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":38442,"source":{"system":"sec-edgar","filing":"0001104659-23-119592","document":"tm2331055-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465923119592/tm2331055-1_4seq1.xml","form_type":"4"}},{"id":1736534,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T17:00:35.000Z","date":"2023-11-15","kind":"exercise","planned":false,"acquired":true,"shares":7457,"price":9.24,"value":68902.68,"ownership":{"direct":true},"balance_after":42324,"source":{"system":"sec-edgar","filing":"0001104659-23-119592","document":"tm2331055-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465923119592/tm2331055-1_4seq1.xml","form_type":"4"}},{"id":1862219,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T16:15:13.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":17300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 6, 2024, or (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":17300,"derivative":{"exercise_price":11.71,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":17300},"source":{"system":"sec-edgar","filing":"0000899243-23-014858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924323014858/doc4.xml","form_type":"4"}},{"id":1990218,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-27T17:02:29.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 23, 2024."}],"balance_after":3886,"derivative":{"underlying":"Common Stock","underlying_shares":3886},"source":{"system":"sec-edgar","filing":"0001104659-23-026082","document":"tm237737-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465923026082/tm237737-16_4seq1.xml","form_type":"4"}},{"id":1990217,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-02-27T17:02:29.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":6293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests  on February 23, 2024."}],"balance_after":6293,"derivative":{"exercise_price":38.6,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":6293},"source":{"system":"sec-edgar","filing":"0001104659-23-026082","document":"tm237737-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465923026082/tm237737-16_4seq1.xml","form_type":"4"}},{"id":1993011,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-24T17:11:07.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3882},"source":{"system":"sec-edgar","filing":"0001104659-23-025376","document":"tm237737-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465923025376/tm237737-2_4seq1.xml","form_type":"4"}},{"id":1993010,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T17:11:07.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34867,"source":{"system":"sec-edgar","filing":"0001104659-23-025376","document":"tm237737-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465923025376/tm237737-2_4seq1.xml","form_type":"4"}},{"id":2055592,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-01-12T17:00:38.000Z","date":"2023-01-10","kind":"exercise","acquired":false,"shares":8722,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.9,"exercise_date":"2014-02-05","expiration_date":"2023-02-05","underlying":"Common Stock","underlying_shares":8722},"source":{"system":"sec-edgar","filing":"0001104659-23-003461","document":"tm233200-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465923003461/tm233200-3_4seq1.xml","form_type":"4"}},{"id":2055591,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T17:00:38.000Z","date":"2023-01-10","kind":"exercise","acquired":true,"shares":8722,"price":7.9,"value":68903.8,"ownership":{"direct":true},"balance_after":30985,"source":{"system":"sec-edgar","filing":"0001104659-23-003461","document":"tm233200-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465923003461/tm233200-3_4seq1.xml","form_type":"4"}},{"id":2231465,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T16:30:40.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 14, 2023, or (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":16300,"derivative":{"exercise_price":4.53,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0000899243-22-022578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924322022578/doc4.xml","form_type":"4"}},{"id":2374557,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-24T21:24:03.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."}],"balance_after":3882,"derivative":{"underlying":"Common Stock","underlying_shares":3882},"source":{"system":"sec-edgar","filing":"0001104659-22-026876","document":"tm227622-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465922026876/tm227622-3_4seq1.xml","form_type":"4"}},{"id":2374556,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-02-24T21:24:03.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":6847,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6847,"derivative":{"exercise_price":32.2,"exercise_date":"2023-02-22","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":6847},"source":{"system":"sec-edgar","filing":"0001104659-22-026876","document":"tm227622-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465922026876/tm227622-3_4seq1.xml","form_type":"4"}},{"id":2378301,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-23T16:16:46.000Z","date":"2022-02-19","kind":"disposition_to_issuer","acquired":false,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4222},"source":{"system":"sec-edgar","filing":"0001104659-22-026100","document":"tm227492d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465922026100/tm227492d2_4seq1.xml","form_type":"4"}},{"id":2378300,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-23T16:16:46.000Z","date":"2022-02-19","kind":"grant","acquired":true,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22263,"source":{"system":"sec-edgar","filing":"0001104659-22-026100","document":"tm227492d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465922026100/tm227492d2_4seq1.xml","form_type":"4"}},{"id":2673949,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T16:45:38.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 8, 2022, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":16300,"derivative":{"exercise_price":5.7,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0000899243-21-022974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924321022974/doc4.xml","form_type":"4"}},{"id":2839132,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-02-23T18:47:54.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022."}],"balance_after":4222,"derivative":{"underlying":"Common Stock","underlying_shares":4222},"source":{"system":"sec-edgar","filing":"0001104659-21-026928","document":"tm217706-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465921026928/tm217706-3_4seq1.xml","form_type":"4"}},{"id":2839131,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-02-23T18:47:54.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":7365,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7365,"derivative":{"exercise_price":29.61,"exercise_date":"2022-02-19","expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":7365},"source":{"system":"sec-edgar","filing":"0001104659-21-026928","document":"tm217706-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465921026928/tm217706-3_4seq1.xml","form_type":"4"}},{"id":3082592,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-07-15T16:39:07.000Z","date":"2020-07-13","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted June 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":2.56,"exercise_date":"2011-11-16","expiration_date":"2020-11-16","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001104659-20-083754","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465920083754/a4.xml","form_type":"4"}},{"id":3082591,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-15T16:39:07.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":920,"price":24.44,"value":22484.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted June 12, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,211 restricted stock units previously reported that will be settled in common stock upon vesting, such vesting to occur on February 21, 2021."}],"balance_after":18041,"source":{"system":"sec-edgar","filing":"0001104659-20-083754","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465920083754/a4.xml","form_type":"4"}},{"id":3082590,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-15T16:39:07.000Z","date":"2020-07-13","kind":"exercise","acquired":true,"shares":8750,"price":2.56,"value":22400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted June 12, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,211 restricted stock units previously reported that will be settled in common stock upon vesting, such vesting to occur on February 21, 2021."}],"balance_after":18961,"source":{"system":"sec-edgar","filing":"0001104659-20-083754","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465920083754/a4.xml","form_type":"4"}},{"id":3113410,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T16:16:40.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":6124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 9, 2021, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":6124,"derivative":{"exercise_price":7.96,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":6124},"source":{"system":"sec-edgar","filing":"0000899243-20-016167","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924320016167/doc4.xml","form_type":"4"}},{"id":3249124,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-02-25T17:24:46.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":9305,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9305,"derivative":{"exercise_price":23.99,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"Common Stock","underlying_shares":9305},"source":{"system":"sec-edgar","filing":"0001104659-20-024852","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465920024852/a4.xml","form_type":"4"}},{"id":3249123,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-25T17:24:46.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":5211,"price":23.99,"value":125011.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit component of the annual equity compensation to directors.  These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021.  Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."}],"balance_after":10211,"source":{"system":"sec-edgar","filing":"0001104659-20-024852","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465920024852/a4.xml","form_type":"4"}},{"id":3482433,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-20T16:15:20.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":6124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 18, 2020, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":6124,"derivative":{"exercise_price":3.37,"exercise_date":"2020-06-18","expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":6124},"source":{"system":"sec-edgar","filing":"0000899243-19-017634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924319017634/doc4.xml","form_type":"4"}},{"id":3632117,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-02-26T19:26:31.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":12427,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12427,"derivative":{"exercise_price":36.75,"exercise_date":"2020-02-22","expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":12427},"source":{"system":"sec-edgar","filing":"0001104659-19-010798","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465919010798/a4.xml","form_type":"4"}},{"id":3876486,"issuer":{"id":155143,"kind":"organization","name":"ARADIGM CORP","symbol":"ARDM"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-03T17:26:28.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":97323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest and become exercisable in four equal quarterly installments over one year beginning on June 29, 2018, subject to such individual continuing to be a Participant (as defined in the 2015 Equity Incentive Plan) on the relevant vesting dates."}],"balance_after":97323,"derivative":{"exercise_price":1.45,"expiration_date":"2028-06-29","underlying":"Common Stock","underlying_shares":97323},"source":{"system":"sec-edgar","filing":"0001123292-18-000852","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013238/000112329218000852/edgar.xml","form_type":"4"}},{"id":3886086,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-21T18:34:00.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":12248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of such stock option shall vest on the first anniversary of the grant date, and the remainder shall vest in equal monthly installments over the following two year period."}],"balance_after":12248,"derivative":{"exercise_price":5.53,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":12248},"source":{"system":"sec-edgar","filing":"0000899243-18-017624","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924318017624/doc4.xml","form_type":"4"}},{"id":4030110,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-02-27T17:45:37.000Z","date":"2018-02-23","kind":"grant","acquired":true,"shares":8613,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8613,"derivative":{"exercise_price":39.4,"exercise_date":"2019-02-23","expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":8613},"source":{"system":"sec-edgar","filing":"0001104659-18-012892","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465918012892/a4.xml","form_type":"4"}},{"id":4280641,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-06-15T16:41:36.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":6036,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6036,"derivative":{"exercise_price":38.6,"exercise_date":"2018-06-13","expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":6036},"source":{"system":"sec-edgar","filing":"0001104659-17-039590","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465917039590/a4.xml","form_type":"4"}},{"id":4293833,"issuer":{"id":155143,"kind":"organization","name":"ARADIGM CORP","symbol":"ARDM"},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-05T17:53:59.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":110485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest and become exercisable in four equal quarterly installments over one year beginning on June 1, 2017, subject to such individual continuing to be a Participant (as defined in the 2015 Equity Incentive Plan) on the relevant vesting dates."}],"balance_after":110485,"derivative":{"exercise_price":1.39,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":110485},"source":{"system":"sec-edgar","filing":"0001123292-17-001082","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013238/000112329217001082/edgar.xml","form_type":"4"}},{"id":4421330,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":60630,"kind":"person","name":"Hudson Frederick M.","position":1,"cik":"0001438462","reported_name":"Hudson Frederick M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-02-27T21:55:56.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":7905,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7905,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":7905},"source":{"system":"sec-edgar","filing":"0001104659-17-012170","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438462/000110465917012170/a4.xml","form_type":"4"}}]}